Neela Cell Therapeutics
PrivateLast Round
Convertible Debt
Nov 24, 2025
Total Funding Raised
$13.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neela Cell Therapeutics is a biotechnology company developing genipin as a treatment for peripheral neuropathy and producing peripheral neurons from human pluripotent stem cells for research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neela Cell Therapeutics Comparables
Compare Neela Cell Therapeutics with similar companies based on industry and business-model similarity.
Neela Cell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Nov 24, 2025 | ||||
| Grant | Jun 1, 2025 |
Neela Cell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2025
$14M round led by Biogen.
- Jun 1, 2025
$50K grant received from Georgia Research Alliance.
Neela Cell Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neela Cell Therapeutics's valuation, stock price, and market status.
Is Neela Cell Therapeutics a public or private company?
Neela Cell Therapeutics is a private company.
What is the current stock price of Neela Cell Therapeutics?
Neela Cell Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Neela Cell Therapeutics worth (valuation)?
Valuation information for Neela Cell Therapeutics is not publicly available.
Can I buy Neela Cell Therapeutics stock?
Neela Cell Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neela Cell Therapeutics's last funding round?
Neela Cell Therapeutics's most recent funding round was Convertible Debt on November 24, 2025.
Who are the main investors in Neela Cell Therapeutics?
Key investors in Neela Cell Therapeutics include Georgia Research Alliance.
Will Neela Cell Therapeutics IPO soon?
No public IPO plans have been announced for Neela Cell Therapeutics.
How can I track Neela Cell Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neela Cell Therapeutics's secondary market activity and sign up for updates.